4 free views remaining today
lung combined type small cell carcinoma
Description
What is Combined Small Cell Lung Carcinoma?
Combined small cell lung carcinoma (C-SCLC) is a rare subtype of lung cancer that accounts for about 2% to 5% of all small cell carcinomas. It is characterized by the presence of both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) components in any relative proportion.
Types of Lung Cancer Involved
In C-SCLC, the SCLC component can be combined with various types of NSCLC, including:
- Adenocarcinoma
- Squamous cell carcinoma
- Large cell neuroendocrine carcinoma
Clinical Features and Prognosis
The clinical features and prognosis of patients with C-SCLC are not fully determined due to the scarcity of studies on this topic. However, it is known that C-SCLC tends to have a more aggressive course than pure SCLC.
Treatment Options
Treatment options for C-SCLC include surgery, chemotherapy, radiation therapy, laser therapy, targeted therapy, and palliative care. The choice of treatment depends on the stage and extent of the disease, as well as the patient's overall health.
References:
- [1] Combined small cell lung carcinoma is defined by the World Health Organization (WHO) as small cell carcinoma combined with an additional component consisting of any non–small cell histologic type. [10]
- [2] C-SCLC accounts for about 2% to 5% of all small cell carcinomas. [2]
- [3] The clinical features and prognosis of patients with C-SCLC are not fully determined due to the scarcity of studies on this topic. [12]
Note: The above information is based on a summary of the search results provided in the context.
Additional Characteristics
- Combined small cell lung carcinoma (C-SCLC) is a rare subtype of lung cancer that accounts for about 2% to 5% of all small cell carcinomas.
- Characterized by the presence of both small cell lung cancer and non-small cell lung cancer components in any relative proportion.
- The SCLC component can be combined with various types of NSCLC, including adenocarcinoma, squamous cell carcinoma, and large cell neuroendocrine carcinoma.
- Tends to have a more aggressive course than pure SCLC.
- Treatment options include surgery, chemotherapy, radiation therapy, laser therapy, targeted therapy, and palliative care.
Signs and Symptoms
Common Signs and Symptoms of Combined Small Cell Carcinoma
Combined small cell carcinoma, also known as combined small cell non-small cell lung cancer, is a rare type of lung cancer that combines the characteristics of both small cell and non-small cell lung cancers. The symptoms of this condition can vary from person to person, but here are some common signs and symptoms:
- Coughing: A persistent cough or worsening cough is one of the most common symptoms of combined small cell carcinoma [5].
- Shortness of breath: Difficulty breathing or feeling winded even when sitting still can be a sign of this condition [7].
- Weight loss: Unintentional weight loss, often accompanied by fatigue and weakness, can be an indication of advanced lung cancer [8].
- Fatigue: Feeling extremely tired or weak, even after resting, is another common symptom [9].
- Loss of appetite: A decrease in appetite or feeling full quickly can also be a sign of this condition [4].
Other Possible Symptoms
In addition to the above symptoms, some people may experience:
- Chest pain or discomfort
- Wheezing or coughing up blood
- Neurological changes such as headache, dizziness, or seizures (in advanced cases)
- Bone pain from metastasis
It's essential to note that these symptoms can also be caused by other conditions, and a proper diagnosis should only be made by a qualified healthcare professional.
References
[4] - The most common signs of lung cancer are a cough that won't go away, chest pain, shortness of breath, weight loss, and fatigue. But just because you have... (Search Result 4) [5] - Symptoms of Small Cell Lung Cancer · Bloody sputum (phlegm) · Chest pain · Cough · Loss of appetite · Shortness of breath · Weight loss · Wheezing. (Search Result 5) [7] - Signs and symptoms of small cell lung cancer include coughing and shortness of breath. Tests and procedures that examine the lungs are used to... (Search Result 7) [8] - Fatigue, anorexia; Neurological compromise; Bone pain from bone mets; Weight loss and debility. Lungs with Small Cell Lung Cancer ( ... (Search Result 8)
Additional Symptoms
- Shortness of breath
- Coughing
- Chest pain or discomfort
- Wheezing or coughing up blood
- Neurological changes such as headache, dizziness, or seizures (in advanced cases)
- weight loss
- bone pain
- loss of appetite
- fatigue
Diagnostic Tests
Diagnostic Tests for Small Cell Lung Cancer
Small cell lung cancer (SCLC) is a fast-growing and aggressive form of lung cancer that requires prompt diagnosis and treatment. The diagnostic process typically involves a combination of imaging tests, biopsies, and other procedures to confirm the presence of SCLC.
Imaging Tests
- Computed Tomography (CT) Scanning: CT scans are often used as the first line of imaging to detect lung cancer. They can help identify tumors in the lungs and surrounding areas [5].
- Magnetic Resonance Imaging (MRI): MRI scans may be used to further evaluate the extent of tumor spread and involvement of other organs [6].
Biopsy Procedures
- Needle Biopsy: A needle biopsy involves inserting a thin needle into the lung tissue to collect cell samples for examination under a microscope. This procedure is often performed under local anesthesia and can provide a definitive diagnosis [9].
- Bronchoscopy: Bronchoscopy involves using a flexible tube with a camera to visualize the airways and collect tissue samples from the lungs [2].
- Mediastinoscopy: Mediastinoscopy is a surgical procedure that allows doctors to examine the mediastinum (the area between the lungs) and collect tissue samples for biopsy [2].
Other Diagnostic Tests
- Chest X-ray: A chest x-ray may be used as an initial screening tool to detect lung cancer, but it is not always accurate in diagnosing SCLC [4].
- Blood Tests: Blood tests can help identify biomarkers associated with SCLC, such as neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP) [12].
Staging Small Cell Lung Cancer
After a diagnosis of SCLC is confirmed, the cancer is staged to determine its extent and spread. This involves evaluating the tumor size, lymph node involvement, and presence of metastasis using imaging tests and biopsies [5].
It's essential to note that each patient's situation is unique, and the diagnostic process may vary depending on individual factors. A multidisciplinary team of healthcare professionals will work together to determine the best course of action for diagnosis and treatment.
References:
[1] Context 2 [2] Context 3, Context 13 [4] Context 14 [5] Context 5 [6] Context 6 [9] Context 9 [12] Context 12
Treatment
Differential Diagnosis
The differential diagnosis of lung combined type small cell carcinoma involves identifying other conditions that may present similarly to this type of cancer.
According to the search results, the differential diagnosis of small cell lung cancer (SCLC) includes:
- Non-small cell lung cancer (NSCLC), including large cell carcinoma or basaloid squamous cell carcinoma [2]
- Malignant lymphoma [2]
- Chronic inflammation [2]
- Other neuroendocrine lung tumors [2]
Additionally, the search results mention that small cell lung carcinoma can also be combined with non-small cell carcinoma in 1 to 3% of cases [13]. A useful panel for this differential diagnosis includes CD45, CD20, CD3, or CD30 for large cell lymphomas [13].
It's worth noting that the search results also highlight the importance of distinguishing small cell lung carcinoma from other conditions, such as basaloid squamous cell carcinoma or non-Hodgkin's lymphoma, which can have similar characteristics [14].
In terms of specific features that may help with differential diagnosis, the search results mention that small cell lung carcinoma is associated with paraneoplastic syndromes, most commonly Cushing syndrome, due to increased production of adrenocorticotropic hormone [10].
Additional Information
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_5409
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_3094
- owl#annotatedSource
- t437385
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:5421
- core#notation
- DOID:5421
- oboInOwl#hasDbXref
- UMLS_CUI:C1333125
- IAO_0000115
- A lung small cell carcinoma that is characterized as a multiphasic lung cancer comprised of a mixture of small cell and non-small cell lung carcinoma cells.
- oboInOwl#hasExactSynonym
- Combined small cell carcinoma of the lung
- oboInOwl#hasRelatedSynonym
- combined type small cell carcinoma of lung
- rdf-schema#label
- lung combined type small cell carcinoma
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.